Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2002

01-05-2002 | Case Report

Diagnostic Significance of Measurement of the Receptor for Urokinase-Type Plasminogen Activato on Granulocytes and in Plasma from Patients with Paroxysmal Nocturnal Hemoglobinuria

Authors: Weiqiang Gao, Zhaoyue Wang, Xia Bai, Yuyun Li, Changgeng Ruan

Published in: International Journal of Hematology | Issue 4/2002

Login to get access
Metadata
Title
Diagnostic Significance of Measurement of the Receptor for Urokinase-Type Plasminogen Activato on Granulocytes and in Plasma from Patients with Paroxysmal Nocturnal Hemoglobinuria
Authors
Weiqiang Gao
Zhaoyue Wang
Xia Bai
Yuyun Li
Changgeng Ruan
Publication date
01-05-2002
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02982138

Other articles of this Issue 4/2002

International Journal of Hematology 4/2002 Go to the issue

Case Report

Failure to Detect Epstein-Barr Virus (EBV) DNA in Plasma by Real-Time PCR in a Case of EBV-Associated Posttransplantation Lymphoproliferative Disorder Confined to the Central Nervous System

OriginalPaper

Analyzing the Roles of Mast Cells and Basophils in Host Defense and Other Biological Responses

OriginalPaper

Cytokines Regulate Development of Human Mast Cells from Hematopoietic Progenitors

Review Article

Leukemogenic Risk of Hydroxyurea Therapy as a Single Agent in Polycythemia Vera and Essential Thrombocythemia: N-and K-ras Mutations and Microsatellite Instability in Chromosomes 5 and 7 in 69 Patients

OriginalPaper

Mast Cells Derived from Embryonic Stem Cells: A Model System for Studying the Effects of Genetic Manipulations on Mast Cell Development, Phenotype, and Function In Vitro and In Vivo

Review Article

cDNA Microarray Analysis of Chronic Myeloid Leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits